Seattle, WA, Dec. 19, 2017 -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that Friday Night Inc. (CSE: TGIF) (CNSX: TGIF) (TGIF.CN) (OTCQB: TGIFF) has engaged CFN Media to conduct a four-month investor and market visibility program that began on December 13, 2017.
“Friday Night has already become a leader in Nevada’s fast growing cannabis market with its Las Vegas cannabis operation and hemp-based CBD products business”, said Frank Lane, President of CFN Media. “We are very pleased to be working with the company as it expands operations in Nevada and beyond.”
Brayden Sutton, CEO of Friday Night Inc. stated, “We are very pleased to be working with Frank Lane and his team at CFN Media. CFN does a tremendous job with investor outreach in the United States and we look forward to bringing our story to a new audience.”
CFN Media will leverage its extensive reach to mainstream and cannabis-focused investors and media across North America to attract high-quality investors to Friday Night Inc. while elevating the company’s financial brand.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN), the leading creative agency and media network dedicated to the worldwide cannabis industry, helps marijuana companies attract investors, customers (B2B, B2C), capital, and publicity. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
The company launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
About Friday Night Inc.
Friday Night Inc. is a Canadian public company, which owns and controls cannabis and hemp based assets in Las Vegas Nevada. The company owns 91% of Alternative Medicine Association, LC (AMA), a licensed medical and adult-use cannabis cultivation and production facility that produces its own line of unique cannabis-based products and manufactures other third-party brands. Infused MFG, also a 91% owned subsidiary, produces hemp-based, CBD products, thoughtfully crafted of high quality organic botanical ingredients. Friday Night Inc. is focused on strengthening and expanding these operations within and outside of the state.
Contact: Frank Lane 206 369 7050 [email protected]


Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 



